Redox regulation of the UPR sensor Ire1

UPR 传感器 Ire1 的氧化还原调节

基本信息

  • 批准号:
    10538082
  • 负责人:
  • 金额:
    $ 4.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-21 至 2024-08-20
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The oxidative protein folding machinery in the endoplasmic reticulum (ER) is currently appreciated as a potentially significant source of reactive oxygen species (ROS). Yet, few specific mechanisms have been described as to how cells manage ROS production at the ER and/or adapt to an accumulation of ER ROS. With little understanding of the pathways for ER ROS management in cells, how dysregulation of ER ROS levels contributes to disease is under-explored. The research goal of this proposal is to elucidate how cells use ROS generated in the ER lumen to initiate signals that promote healthy ROS levels and allow survival through conditions of oxidative ER stress. In order to dissect the molecular mechanisms specific to the production of ER ROS, the Sevier Lab takes advantage of a mutant of the conserved enzyme Ero1 (Ero1*) as an innovative way to induce a bolus of H2O2 within the ER lumen of S. cerevisiae. Using Ero1* to induce ROS within the ER, I uncovered a role for the UPR sensor Ire1 in sensing ER ROS. Guided by the discovery in C. elegans of a redox switch in the kinase domain of IRE-1 that can be activated by cytoplasmic ROS, I have established that genetically blocking Ire1 oxidation at the conserved cysteine (Ire1-C832S) results in enhanced Ire1 enzymatic activity during Ero1* treatment, consistent with UPR dampening as a consequence of C832 oxidation. Based on these data, I hypothesize that ROS generated in the ER lumen during protein folding can oxidize Ire1 C832 in the cytoplasm and initiate an antioxidant response that allows cells to adapt to the unique stress of excess ER ROS. To test this hypothesis, in Aim 1 I will determine the oxidation status of Ire1 when Ero1* over-expression generates a buildup of H2O2 in the ER lumen, and I will show that Ire1 modification occurs at C832. Additionally, I will establish that it is the movement of H2O2 from the ER lumen into the cytosol that facilitates Ire1 modification. In Aim 2, I will assess whether the loss in canonical Ire1 activation is associated with a gain of a new function in antioxidant signaling. My proposed research project is coupled to a broader training plan that will ensure success as I work toward becoming a research group leader. I identified mentoring as a complex professional skill I want to improve. My Sponsors and I have outlined a training plan that will both strengthen my technical and communication skills and also hone my proficiency as a mentor. Specifically, I put forward a plan to integrate the characterization of the biochemical effect(s) of Ire1 oxidation with the mentoring of an undergraduate student that will complete a straightforward analysis of the impact for Ire1 oxidation on Ire1 kinase and RNase activities. I believe the support of my individual Sponsors nestled within the intellectually exciting environment of the Cornell University Biochemistry, Molecular, and Cell Biology graduate program primes me for personal scientific and professional successes.
项目摘要/摘要 内质网(ER)中的氧化蛋白质折叠机制目前被认为是 潜在的重要来源的活性氧类(ROS)。然而,几乎没有具体的机制被 描述了细胞如何在内质网管理ROS的产生和/或适应ER RO的积累。使用 对细胞内ER ROS管理的途径以及ER ROS水平的异常调节知之甚少 对疾病的影响还没有得到充分的研究。这项建议的研究目标是阐明细胞如何使用ROS 在内质网管腔中产生,以启动信号,促进健康的ROS水平,并通过 氧化内质网应激的条件。为了剖析内质网产生的特定分子机制 ROS,Sevier实验室利用保守酶Ero1(Ero1*)的突变体作为一种创新方式 在酿酒酵母的内质网管腔内诱导一团过氧化氢。使用Ero1*在内质网内诱导RO,即 发现了UPR传感器IRE1在感应ER ROS中的作用。在线虫中发现了一种氧化还原 在可以被细胞质ROS激活的IRE-1的激动域中切换,我已经建立了 在保守的半胱氨酸(IRE1-C832S)上通过基因阻断IRE1氧化导致IRE1酶活性增强 在Ero1*处理期间的活性,与C832氧化导致的UPR抑制一致。基于 这些数据,我假设,在蛋白质折叠过程中,内质网管腔中产生的ROS可以氧化IRE1 C832在 细胞质并启动抗氧化反应,使细胞适应过量内质网的独特压力 罗斯。为了验证这一假设,在目标1中,我将确定当Ero1*过表达时IRE1的氧化状态 在内质网管腔中产生过氧化氢积聚,我将证明IRE1修饰发生在C832。另外, 我将确定是过氧化氢从内质网腔到胞浆的运动促进了IRE1的修饰。 在目标2中,我将评估规范的IRE1激活的丧失是否与在 抗氧化剂信号。我提议的研究项目与确保成功的更广泛的培训计划相结合 当我努力成为一名研究小组组长的时候。我认为辅导是我想要的一项复杂的专业技能 以求提高。我的赞助商和我已经概述了一项培训计划,该计划将加强我的技术和 沟通技巧,也磨练了我作为导师的熟练程度。具体地说,我提出了一个计划,将 在本科生指导下描述IRE1氧化的生化效应(S) 这将完成对IRE1氧化对IRE1激酶和核糖核酸酶活性的影响的直接分析。 我相信我的个人赞助商的支持是在康奈尔大学令人兴奋的智力环境中实现的 大学生物化学、分子和细胞生物学研究生课程为我个人科学和 职业上的成功。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Marie Roscoe其他文献

Jennifer Marie Roscoe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Marie Roscoe', 18)}}的其他基金

Redox regulation of the UPR sensor Ire1
UPR 传感器 Ire1 的氧化还原调节
  • 批准号:
    10680424
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 4.32万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了